Considering Robotic Surgery For Breast Cancer? Proceed With Caution, FDA Says

Though the FDA has approved robotic assisted surgery for many procedures, the US agency cautions that safety and efficacy of the technology has not been well-established for cancer-related surgeries, particularly mastectomies.

In many cases, robotically assisted surgery (RAS) offers patients a less invasive procedure than traditional surgery, with smaller incisions and less scarring, lower infection rates, quicker recovery and reduced pain.

But the Food and Drug Administration is reminding breast cancer patients that RAS might not be the best option for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Planning To Take Part in MDUFA? FDA Wants To Hear From You

07 Jul 2025

• By Brian Bossetta

The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.

Finland Cracks Down On Software That Needs Regulating As A Medical Devices

07 Jul 2025

• By Amanda Maxwell

Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it. 

Investors Urged To Prioritize Patient Engagement To Ensure Clients’ Products Succeed

04 Jul 2025

• By Amanda Maxwell

To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.

EU Life Sciences Strategy Must Address ‘Regulatory Lasagna’

03 Jul 2025

• By Amanda Maxwell

MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

03 Jul 2025

• By Vibha Sharma

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.